STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) CCO exercises 54,000 RSUs; 18,711 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MariMed Inc. Chief Commercial Officer Ryan Crandall reported compensation-related equity activity. He exercised 54,000 Restricted Stock Units (RSUs), which converted into an equal number of common shares. In connection with this vesting, 18,711 common shares were withheld by MariMed to cover tax obligations, rather than sold on the open market. Following these transactions, Crandall directly holds 958,140 shares of MariMed common stock, reflecting a routine RSU vesting and associated tax-withholding disposition.

Positive

  • None.

Negative

  • None.
Insider Crandall Ryan
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units (RSU) 54,000 $0.00 --
Exercise Common stock 54,000 $0.00 --
Tax Withholding Common stock 18,711 $0.0755 $1K
Holdings After Transaction: Restricted Stock Units (RSU) — 0 shares (Direct, null); Common stock — 958,140 shares (Direct, null)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. The RSUs were granted on June 8, 2023; there are no outstanding RSUs remaining under this grant, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
RSUs exercised 54,000 units RSUs converted one-for-one into common stock on June 8, 2026
Shares withheld for taxes 18,711 shares Common stock withheld to satisfy RSU-related tax obligations
Tax value per share $0.0755 per share Reported value used for tax-withholding disposition
Post-transaction holdings (step 1) 939,429 shares Direct common stock holdings after tax-withholding transaction
Post-transaction holdings (final) 958,140 shares Direct common stock holdings after RSU exercise
Restricted Stock Units (RSU) financial
"security_title: "Restricted Stock Units (RSU)""
tax withholding obligations financial
"shares of common stock withheld by the Issuer to satisfy tax withholding obligations"
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
one-for-one basis financial
"RSUs convert to shares of common stock on a one-for-one basis"
award agreement financial
"in accordance with the terms of an award agreement between the Issuer and the Reporting Person"
An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Crandall Ryan
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock06/08/2026M54,000A$0(1)958,140D
Common stock06/08/2026F18,711(2)D$0.0755939,429D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)06/08/2026M54,000 (3) (3)Common Stock, par value $.001 per share54,000$00D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The RSUs were granted on June 8, 2023; there are no outstanding RSUs remaining under this grant, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Ryan Crandall06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MariMed (MRMD) report for Ryan Crandall?

MariMed reported that Chief Commercial Officer Ryan Crandall exercised 54,000 Restricted Stock Units, which converted into 54,000 common shares. A portion of these shares was withheld by the company to satisfy tax obligations related to the RSU vesting event.

How many RSUs did MariMed’s CCO convert to common stock?

Ryan Crandall converted 54,000 Restricted Stock Units into 54,000 shares of MariMed common stock. The RSUs convert on a one-for-one basis, consistent with the award agreement terms disclosed, completing this specific RSU grant from June 8, 2023.

Were the MariMed (MRMD) insider transactions open-market sales or tax withholding?

The filing shows a tax-withholding disposition, not an open-market sale. MariMed withheld 18,711 common shares to cover tax obligations triggered by the vesting of Ryan Crandall’s RSUs, consistent with standard equity compensation practices.

How many MariMed shares does Ryan Crandall hold after these transactions?

After the exercise and related tax withholding, Ryan Crandall directly holds 958,140 shares of MariMed common stock. This post-transaction holding figure is reported in the Form 4 as his direct ownership position following the June 8, 2026 activity.

What does the Form 4 say about Ryan Crandall’s remaining RSUs at MariMed?

The Form 4 notes there are no RSUs remaining under this specific June 8, 2023 grant. All 54,000 RSUs were converted into common shares, fully exhausting that award in accordance with the related equity award agreement between MariMed and Crandall.

At what price were shares withheld for MariMed’s tax obligations?

The tax-withholding disposition is reported at a price of $0.0755 per share for 18,711 common shares. This figure reflects the value used to determine how many shares were retained by MariMed to satisfy Ryan Crandall’s RSU-related tax liabilities.